Abstract
Endothelial cells play a critical role in the process of angiogenesis during skin wound healing. The migration and proliferation of endothelial cells are processes that are initiated by the hypoxic microenvironment in a wound, but the underlying mechanisms remain largely unknown. Here, we identified a novel role for microtubule-associated protein 4 (MAP4) in angiogenesis. We firstly demonstrated that MAP4 phosphorylation was induced in hypoxic endothelial cells; the increase in MAP4 phosphorylation enhanced the migration and proliferation of endothelial cells. We also found that hypoxia (2% O2) activated p38/mitogen-activated protein kinase (MAPK) signaling, and we identified p38/MAPK as an upstream regulator of MAP4 phosphorylation in endothelial cells. Moreover, we showed that the promigration and proproliferation effects of MAP4 phosphorylation were attributed to its role in microtubule dynamics. These results indicated that MAP4 phosphorylation induced by p38/MAPK signaling promotes angiogenesis by inducing the proliferation and migration of endothelial cells cultured under hypoxic conditions via microtubule dynamics regulation. These findings provide new insights into the potential mechanisms underlying the initiation of the migration and proliferation of endothelial cells.
Introduction
Endothelial cell (EC) proliferation and migration are essential processes during wound healing, due to their roles in angiogenesis (Munoz-Chapuli et al., 2004; Lamalice et al., 2007; Banyard et al., 2016), which is required to restore oxygen and nutrient supplies (DiPietro, 2013). However, if angiogenesis is deregulated, wounds may not heal. Upon wounding, hypoxia occurs at the wound edge due to the interrupted oxygen supply and excessive oxygen consumption (Falanga, 1988; O’Toole et al., 1997; Yip, 2015). The hypoxic microenvironment has been proven to be an important initial factor for the healing skin wounds, but the underlying mechanisms remain largely unknown.
Microtubules (MTs) are one of the major components of the eukaryotic cytoskeleton, and they are composed of α and β-tubulin heterodimers; they have a variety of biological functions, such as mediating cell mitosis, cell movement, and integrating transmembrane signals in many eukaryotic cells, including ECs (Liu et al., 1998; Kreitzer and Myat, 2018; LaFlamme et al., 2018). The transition between the polymerization and depolymerization of α- and β-tubulin is defined as MT dynamics, which is regulated by destabilizing proteins (e.g., stathmin family) (Cassimeris, 2002; Giampietro et al., 2005) and stabilizing proteins, such as microtubule-associated proteins (MAPs) (Kremer et al., 2005). MAP4, the major MAP protein expressed in non-neuronal mammalian cells, is capable of regulating MT assembly and stability both in vitro and in vivo. The phosphorylation of MAP4 impairs its function and induces its detachment from MTs, resulting in the depolymerization of MTs. The crucial phosphorylation sites in human MAP4 responsible for altering its function are S768 and S787 (Srsen et al., 1999; Kitazawa et al., 2000; Hu et al., 2010). It has been reported that MAP4 phosphorylation affects cell cycle progression (Chang et al., 2001) and apoptosis (Hu et al., 2014). MAP4 was recently shown to promote cell invasion in the progression of solid tumors (Ou et al., 2014; Jiang et al., 2016; Xia et al., 2018). To date, the contributions of MAP4 phosphorylation to the proliferation and migration of ECs during angiogenesis remain largely unknown.
Previously, we reported that p38/mitogen-activated protein kinase (MAPK) induces MAP4 phosphorylation and MT disassembly in hypoxic cardiomyocytes (Hu et al., 2014). In addition, p38/MAPK is an important kinase required for the cytoskeletal reorganization that precedes the migration and proliferation of various cell types (Huang et al., 2004). Therefore, MAP4 phosphorylation controlled by p38/MAPK may regulate MT dynamics, migration, and proliferation in ECs.
Hypoxic stress after acute injuries stimulates gene expression and growth factor synthesis, contributing to wound angiogenesis (Yip, 2015). Here, we reported that MAP4 phosphorylation promoted the migration and proliferation of ECs subjected to short-term hypoxia (2% O2). Additionally, MAP4 phosphorylation was induced in response to hypoxia through the activation of p38/MAPK signaling. Mechanistically, MAP4 phosphorylation increased cell migration and proliferation by mediating MTs dynamics in ECs. Together, our data suggested a novel role for MAP4 phosphorylation in angiogenesis.
Results
Hypoxia Promotes the Migration and Proliferation of Endothelial Cells (ECs)
Migration and proliferation of ECs are critical processes for angiogenesis during wound repair (DiPietro, 2013). Human umbilical vein endothelial cells (HUVECs) and human dermal microvascular endothelial cells (HDMECs) were subjected to hypoxia for 6, 12, or 24 h to determine the effect of hypoxia on ECs. The motility of single cells was assessed. Remarkably, hypoxia enhanced cell motility in a time-dependent manner, with the maximum effect achieved after treatment with 2% O2 for 12 h, as shown by a larger range of cell trajectories and greater velocity of cell movement (Figure 1A,B). Then, a scratch wound healing assay was performed to evaluate the migratory activity of the cells cultured under hypoxia (2% O2 for 12 h). As expected, the migration of hypoxic HDMECs and HUVECs was significantly increased compared to normoxic cells, as shown by the increased percentage of gap closure after wounding (Figure 1C,D). In addition, EdU staining, an advanced method for assessing cell proliferation, revealed a marked increase in the proliferation of HDMECs and HUVECs cultured under hypoxia, as indicated by the positive staining for of 5-ethynyl-2′-deoxyuridine (EdU, green) in cell nuclei (Figure 1E,F). Thus, the migration and proliferation of ECs were indeed enhanced under hypoxic conditions.
FIGURE 1
MAP4 Phosphorylation Is Increased in Hypoxic ECs
Previously, we have revealed an increase in MAP4 phosphorylation in hypoxic cardiomyocytes (Hu et al., 2014). MAP4 phosphorylation was analyzed in HDMECs and HUVECs treated with or without hypoxia using Western blotting to investigate the potential effects of MAP4 phosphorylation on EC proliferation and migration. As shown in Figure 2A,B, low basal levels of MAP4 phosphorylated on S768 and S787 were observed in HDMECs cultured under normoxic condition. However, a marked increase in the levels of phosphorylation at both residues and p-MAP4 was induced in a time-dependent manner in response to hypoxia (2% O2), with MAP4 levels unchanged. Meanwhile, we analyzed the activation of p38/MAPK signaling, which was reported to control the phosphorylation of MAP4 in other contexts (Li et al., 2015, 2018). The activity of the p38/MAPK signaling pathway was low under normoxic conditions, while the hypoxia treatment significantly increased the activation of the p38/MAPK signaling pathway, as determined with a phospho-specific p38/MAPK antibody (Thr180/Tyr182). Furthermore, the observations that the hypoxia treatment increased MAP4 phosphorylation and the activation of p38/MAPK signaling were confirmed in HUVECs (Figure 2C,D).
FIGURE 2
MAP4 Phosphorylation Regulates EC Migration and Proliferation
A MAP4(Ala) mutant was constructed by changing S768 and S787 residues to alanines [MAP4(Ala)] to mimic the non-phosphorylated forms and to elucidate whether the phosphorylation status of MAP4 was involved in EC migration and proliferation. HA-tagged MAP4(Ala) or CMV-null was overexpressed at comparable levels in both HDMECs and HUVECs, as determined by Western blot analysis (Figure 3A). Then, we transfected the MAP4(Ala) mutant or CMV-null into HDMECs and HUVECs prior to the hypoxia treatment (Figure 3A). Consequently, changes in cell migration were determined using two different assays: a single cell motility assay and a scratch wound healing assay. As expected, the migratory capacity of HDMECs and HUVECs in the hypoxic CMV-null group was significantly greater than the normoxic CMV-null group, whereas the migratory capacity was dramatically decreased in MAP4(Ala) transfectants compared with cells transfected with CMV-null under hypoxia stress (Figure 3B–E). Similarly, the increased proliferation of HDMECs and HUVECs subjected to hypoxia was markedly reduced in MAP4(Ala) transfectants compared with cells transfected with CMV-null, as depicted using EdU staining (Figure 3F,G). Based on these observations, MAP4 phosphorylation indeed promoted the migration and proliferation of ECs.
FIGURE 3
P38/MAPK Activation Mediates MAP4 Phosphorylation and the Migration and Proliferation of Hypoxic ECs
We have previously identified MAP4 phosphorylation as a downstream target of p38/MAPK signaling in hypoxic cardiomyocytes and LPS-stimulated human pulmonary microvascular endothelial cells (HPMECs) (Hu et al., 2014; Li et al., 2015). In the present study, p38/MAPK activation and MAP4 phosphorylation were consistently increased in hypoxic HDMECs and HUVECs (Figure 2). We constructed a MKK6(Glu) adenovirus to persistently activate MKK6, which induced p38/MAPK activation, and it was used as the positive control to explore whether the p38/MAPK signaling is involved in hypoxia-induced MAP4 phosphorylation, migration, and proliferation in ECs (Figure 4A). Conversely, the specific p38/MAPK inhibitor SB203580 (SB, 5 μM) was used to inhibit the p38/MAPK signaling pathway in HDMECs and HUVECs under hypoxia (2% O2). MAP4 phosphorylation (p-MAP4, S737, and S760) in the MKK6(Glu) group was significantly increased, and SB (5 μM) decreased MAP4 phosphorylation induced by the hypoxia treatment (Figure 4B). Next, we detected the influence of p38/MAPK activation on EC migration and proliferation. Our observations indicated that the MKK6(Glu) group exhibited a remarkably increased range of cell trajectories and velocity of cell movement in HDMECs and HUVECs cultured under normoxic conditions, while the p38/MAPK inhibitor SB inhibited the hypoxia-induced cell motility (Figure 4C,D). Using the scratch wound healing assay, MKK6(Glu) transfection increased the percentage of gap closure after wounding, while SB significantly delayed the migration of hypoxic HDMECs and HUVECs (Figure 4E,F). In addition, the results of EdU staining, which was applied to assess cell proliferation, demonstrated that MKK6(Glu) transfection induced cell proliferation with a higher percentage of EdU-positive HDMECs and HUVECs cultured under normoxic conditions, while the p38/MAPK inhibitor remarkably reduced the proliferation of hypoxic HDMECs and HUVECs (Figure 4G,H). Thus, p38/MAPK was a critical upstream regulator of MAP4 phosphorylation and induced the migration and proliferation of HDMECs and HUVECs under hypoxic stress.
FIGURE 4
MAP4 Phosphorylation Plays a Role in p38/MAPK Signaling-Induced EC Migration and Proliferation
Furthermore, we determined whether MAP4 phosphorylation was involved in p38/MAPK -mediated EC migration and proliferation in response to hypoxia. HDMECs and HUVECs were transiently transfected with MAP4(Ala), MKK6(Glu), or both constructs. MKK6(Glu) transfection notably increased p38/MAPK activation, which was not influenced by MAP4(Ala) and MKK6(Glu) cotransfection, as determined using Western blotting (Figure 5A,B), further confirming that p38/MAPK was the upstream kinase responsible for MAP4 phosphorylation and the observations described above. As expected, MKK6(Glu) increased the range of cell trajectories and the velocity of cell movement. Interestingly, MAP4(Ala) overexpression significantly abolished the p38/MAPK-induced cell motility (Figure 5C,D). In the scratch wound healing assay, MAP4(Ala) suppressed the migration of HDMECs and HUVECs induced by MKK6(Glu) transfection (Figure 5E,F). In addition, MAP4(Ala) overexpression significantly abrogated the MKK6(Glu)-induced cell proliferation, as depicted by a decrease in the percentage of EdU-positive HDMECs and HUVECs (Figure 5G,H). Taken together, these observations denoted an essential role for MAP4 phosphorylation in p38/MAPK-induced EC migration and proliferation.
FIGURE 5
The p38/MAPK Signaling Pathway Involved in the MAP4 Phosphorylation- Mediated MT Depolymerization in Hypoxic ECs
Previously, the balance between MAP4 phosphorylation and dephosphorylation has been shown to be an essential factor that controls microtubule (MT) assembly and stabilization. Once phosphorylated, MAP4 dissociates from MTs, leading to MT disruption (Ramkumar et al., 2018). MTs have fundamental roles in many essential biological processes ranging from intracellular trafficking and the positioning of cellular components in interphase to the formation of mitotic spindle during cell proliferation and the maintenance of cell morphology and cell motility (Kaverina and Straube, 2011; Akhmanova and Steinmetz, 2015; Steinmetz and Prota, 2018). Thus, we analyzed the roles of p38/MAPK signaling and MAP4 phosphorylation in MT depolymerization in hypoxic HDMECs and HUVECs. The MAP4(Ala) mutant was overexpressed in the two EC lines prior to the hypoxia treatment. Western blots showed that MAP4(Ala) transfection reversed the reduced levels of polymerized tubulin and increased the levels of free tubulin in hypoxic cells (Figure 6A). The MT morphology in the indicated cells was observed using a confocal microscope (Figure 6C). In HDMECs and HUVECs, the MTs of CMV-null group were well-organized and displayed a faint, uniformly distributed lattice network, whereas the cells under hypoxia stress showed clear signs of MT disruption and modification, as manifested by a less regular organization and some breakages along the edges of the cell or in the vicinity of the nuclei. Thus, the MTs were depolymerized. After transfection with MAP4(Ala), MT disruption was suppressed and reversed. These data indicated that MAP4(Ala) protected ECs from hypoxia-induced MT depolymerization.
FIGURE 6
P38/MAPK is an important regulator of MT dynamics, which are involved in many different cellular events (Hu et al., 2014; Li et al., 2015; You et al., 2016). The finding that p38/MAPK regulated MAP4 phosphorylation, which has been shown to control MT stabilization in ECs, motivated us to assess the role of MAP4 phosphorylation in p38/MAPK-induced MT dynamics. ECs overexpressing MAP4(Ala) were significantly more resistant than the CMV-null control ECs to MT disassembly in response to MKK6(Glu) transfection, as assessed using MT immunofluorescence staining and a tubulin fraction analysis (Figure 6B,D). These findings were consistent with our concept of a critical role for MAP4 phosphorylation in p38/MAPK-mediated MT depolymerization in hypoxic ECs.
Discussion
Angiogenesis is a complex process that requires the coordinated migration and proliferation of ECs to form a lumen-containing tubular vessel with blood flow. Here, we analyzed the role of MAP4 phosphorylation-mediated microtubule disassembly in EC migration and proliferation. The salient findings presented here revealed that MAP4 phosphorylation (S768 and S787)-dependent MT disassembly was required for EC migration and proliferation, as determined in HDMECs and HUVECs. Moreover, our data demonstrated that hypoxia upregulated MAP4 phosphorylation through the activation of p38/MAPK signaling in ECs, which contributed to MT disassembly, and subsequently enhanced cell migration and proliferation (Figure 7).
FIGURE 7
Hypoxia stimulates a variety of intracellular signaling pathways that regulate the proliferation, migration, and survival of various cell types (Xing et al., 2011; Joseph et al., 2015; Nagaraju et al., 2015). Previously, the early use of semi-occlusive dressings (inducing a hypoxic microenvironment) after wounding promoted wound repair compared with wounds that were allowed to air dry (Hopf and Rollins, 2007), but the precise mechanisms were still incompletely elucidated. Some investigators have mainly focused on keratinocyte migration under hypoxia stress (O’Toole et al., 1997; Zhang et al., 2017). To date, the role of the wound hypoxic microenvironment in the biological behavior of vascular ECs has received little attention. As one of the major cell types that participate in wound repair, ECs proliferate from the original vascular bed and migrate to the wound bed to produce a new capillary network, eventually reconstructing the blood circulation to replenish oxygen and energetic substances for re-epithelialization. Based on the ex vivo results from the present study, hypoxia (2% O2) enhanced the migration and proliferation of HDMECs and HUVECs. These observations provide a novel mechanism for the early hypoxia-induced wound repair from the perspective of vascular ECs.
MAP4 is mainly expressed in non-neuronal tissues and is ubiquitously present in all cell types (Parysek et al., 1984). The phosphorylation of the serine sites in its microtubule-binding domain regulates microtubule dynamics (Srsen et al., 1999; Kitazawa et al., 2000; Chang et al., 2001; Hu et al., 2014). Altered levels of MAP4 phosphorylation affect cell cycle progression (Ookata et al., 1995; Ramkumar et al., 2018). Recently, some studies have reported a role for MAP4 in human cancers. For instance, the cAMP/PKA pathway is involved in bladder cancer cell invasion by targeting MAP4-dependent MT dynamics (Ou et al., 2014). Overexpression of MAP4 is associated with a poor prognosis of esophageal squamous cell carcinoma and promotes cell invasion and migration through the MAP4-ERK-Jun-VEGF signaling pathway (Jiang et al., 2016). MAP4 knockdown efficiently suppresses lung adenocarcinoma cell migration and invasion (Xia et al., 2018). Moreover, the microtubule destabilizer stathmin promotes the epithelial–mesenchymal transition (EMT) and metastasis of tumor cells by reducing microtubule polymerization (Li et al., 2011), which validates the role of microtubule dynamics in cell migration. Consistent with these findings, the inhibition of MAP4 phosphorylation notably suppressed the hypoxia-induced EC migration and proliferation through MT disassembly in the present study. These results indicate a promigration and proproliferation effect of MAP4 phosphorylation mediated by regulating microtubule dynamics.
Mitogen-activated protein kinases are important regulators of signal transduction upon exposure to stress-induced stimuli or extracellular growth factors and are crucial for the control of numerous cellular processes, including proliferation, migration and survival (Kim and Choi, 2010). The p38/MAPK signaling pathway is activated in multiple cells under hypoxic conditions (Hirota et al., 2015; Park and Rongo, 2016; Chen et al., 2018), and MKK6 is recognized as a specific upstream regulator of p38/MAPK signaling (Stramucci et al., 2018). As shown in our previous studies, p38/MAPK was upregulated through ROS generation in keratinocytes under hypoxia stress (Zhang et al., 2019). Meanwhile, the activation of the p38/MAPK pathway is implicated in MAP4 phosphorylation in hypoxic cardiomyocytes (Hu et al., 2014; Li et al., 2018). We investigated the effect of p38/MAPK signaling on MAP4 phosphorylation to obtain further insights into the phosphorylation of MAP4 in ECs under hypoxia. Consistently, the specific inhibitor SB203580 and the endogenous activator of p38/MAPK MKK6(Glu) confirmed that the p38/MAPK pathway was required for the hypoxia-induced migration and proliferation of ECs by inducing MAP4 phosphorylation and MT disassembly.
In summary, our current work reveals a novel mechanism underlying the hypoxia-induced migration and proliferation of ECs. MAP4 phosphorylation controlled by p38/MAPK signaling under hypoxia promotes the migration and proliferation of ECs by inducing MT disassembly. Furthermore, our results provide a potential target for development of new treatments for angiogenesis.
Materials and Methods
Cell Culture
Human dermal microvascular endothelial cells were obtained from ScienCell Research Laboratories (San Diego, CA, United States) and cultured in endothelial cell medium (ECM) supplemented with 5% fetal bovine serum (FBS, ScienCell Research Laboratories), 1% endothelial cell growth supplement (ECGS, ScienCell Research Laboratories), and a 1% penicillin/streptomycin (P/S) solution (ScienCell Research Laboratories, 100 U/ml penicillin and 100 μg/ml streptomycin). HUVECs were obtained from the American Type Culture Collection (ATCC, United States) and cultured in RPMI 1640 medium (SH30809, HyClone) containing 10% FBS (10100139, Gibco), 100 U/ml penicillin, and 100 μg/ml streptomycin (Beyotime, China). The cells were incubated at 37°C in a 5% CO2 atmosphere with 95% humidity.
Hypoxia Exposure
Hypoxic conditions of 2% O2, 5% CO2, and 93% N2 were maintained by providing a constant flow of nitrogen using a Forma Series II Water Jacket CO2 incubator (model: 3131; Thermo Scientific), which maintained the desired temperature (37°C) and O2 level. A p38 inhibitor (SB203580 (SB), Selleck, 5 μM) was added to the medium and incubated with the cells at 37°C for 30 min before the hypoxia treatment.
Scratch Wound Healing Assay and Quantitative Analysis
Monolayers of cells plated in 6-well plates were scratched with a 10-μl plastic pipette tip an incubation at 37°C for 2 h with mitomycin-C (S8146, Selleck, final concentration: 5 μg/mL) to inhibit cell proliferation, and then rinsed with medium to remove any cell debris (Zhang et al., 2017). The wound healing process was monitored with an inverted light microscope (Olympus, Japan). The cellular migratory capacity was defined as the rate of wound closure (%), which was analyzed using NIH ImageJ software1.
Single Cell Motility Assay and Quantitative Analysis
Cells were seeded into 24-well plates at a density of 0.5 × 104 cells/cm2 in the corresponding medium. Then, time- lapse imaging was performed with a Zeiss imaging system (Carl Zeiss Meditec, Jena, Germany), which was equipped with a CO2- and temperature-controlled chamber. Images were acquired every 10 min for 6 h. Later, cell trajectories were obtained by tracing the position of the cell nucleus at frame intervals of 6 min using NIH ImageJ software, and the velocity (μm/min) of each cell was defined as the total length (μm) of the trajectories divided by the time (min), which reflected cell motility.
Site-Directed Mutagenesis of MAP4 and MKK6, Recombinant Adenovirus Construction and Transduction
Primers were designed to generate point mutations in MAP4 (S768A and S787A) through polymerase chain reaction reactions using the QuikChange® Multi Site-Directed Mutagenesis Kit, and the MKK6(Glu) adenovirus was constructed as previously described (Hu et al., 2014; Li et al., 2018). Both adenoviruses were constructed by the GeneChem Company (Shanghai, China) and applied according to the manufacturer’s instructions.
Western Blot Analysis
Cellular extracts were prepared in RIPA lysis buffer (P0013, Beyotime) for Western blotting and centrifuged at 14,000 rpm for 15 min at 4°C. Supernatants were collected and protein concentrations were determined using a Bradford Protein Quantification Kit (500-0205, Bio-Rad Laboratories). Protein extracts were loaded and separated on SDS-PAGE gels and then transferred to PVDF membranes (Millipore). Membranes were incubated with specific primary antibodies overnight at 4°C. Subsequently, membranes were incubated with secondary antibodies and visualized using a ChemiDoc XRS System (Bio-Rad Laboratories). Primary antibodies used for immunoblotting were: anti-phospho-p38 (p-p38), anti-p38, anti-β-actin, and anti-VDAC purchased from Cell Signaling Technology and were diluted 1:1000; anti-phospho-MAP4 (p-MAP4) and anti-p-MAP4(S787) purchased from GL Biochem were diluted 1:1000; anti-GAPDH (1:5000) and anti-α-tubulin (1:1000) purchased from Proteintech; anti-MAP4 (1:100) purchased from Bethyl; and anti-p-MAP4 (S768) (1:1000) purchased from Biolegend. The in-house rabbit polyclonal antibodies against p-MAP4(S787) was raised against the C-terminal 14 amino acids, KVAEKRT(pS)PSKPSSA, and the respective non-phosphorylated peptides, as described and validated in our previous report (Hu et al., 2014; Li et al., 2018). Here, we raised and validated the rabbit polyclonal antibody against p-MAP4 using the amino acids QAKVG(pS)LDNVGHLPAGc, and the respective non-phosphorylated peptides conjugated to bovine serum albumin (BSA) (Supplementary Figure S1).
Immunofluorescence Staining of MTs
Cells cultured on glass coverslips were fixed with 4% paraformaldehyde for 20 min, permeabilized with 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 25 min, and then blocked with 10% goat serum for 1 h. For the staining of MT structures, a rabbit anti-α-tubulin primary antibody (1:100, Proteintech, United States) was diluted with PBS, and the coverslips were incubated at 4°C overnight. The coverslips were washed with PBS and then incubated with a goat anti-rabbit secondary antibody conjugated to cyanine 3 (Cy3, 1:100) for 1 h at 37°C. The cells were imaged using a confocal microscope (Leica Microsystems, Wetzlar, Germany).
Cell Proliferation Assay
5-Ethynyl-2′-deoxyuridine (EdU) is a thymidine analog whose incorporation is used to label cells undergoing DNA replication (Salic and Mitchison, 2008). Cell proliferation was determined with the EdU assay using the Click-iT® EdU imaging detection kit, according to the manufacturer’s instructions (BCK488-IV-IM-S, Sigma, United States). The EdU-positive cells are defined as proliferating cells. The fluorescent images were finally obtained using a Leica Confocal Microscope (Leica Microsystems, Germany).
Extraction and Quantification of Tubulin Fractions
The free and polymerized tubulin fractions were isolated using a previously described method (Putnam et al., 1998). Cells cultured in 6-well plates were washed twice with an MT stabilization buffer (MTSB, 37°C) containing 0.1 M piperazine-N, N′-bis (2-ethanesulfonic acid, pH 6.8) (PIPES), 2 mM ethylene glycol-bis (β-aminoethylether)-N, N, N′, N′-tetraacetic acid (EGTA), 2 mM ethylenediaminetetraacetic acid (EDTA), 0.5 mM MgCl2, and 20% glycerol. Cells were incubated with MTSB + 0.1% Triton X-100 + protease inhibitor cocktail (Sigma-Aldrich) + phenylmethylsulfonyl fluoride (PMSF, Sigma-Aldrich) + phosphatase inhibitor cocktail (Sigma-Aldrich). Western blots were performed to analyze the polymerized and free tubulin fractions.
Statistical Analysis
All data are presented as the means ± SEM. Comparisons between two groups were performed using a two-tailed unpaired t-test. The statistical significance of differences among three or more groups was assessed using a one-way analysis of variance (ANOVA). P < 0.05 was considered a significant difference.
Statements
Author contributions
YH supervised the study. LL and JZ designed the experiments with help from JH and DZ. JZ, LL, and QZ performed the experiments with help from XY, CZ, XZ, HS, BC, and YLi. JZ, LL, and YLv analyzed the data. JZ, LL, and JH cowrote the manuscript. All authors discussed the results and commented on the manuscript.
Funding
This study was supported by the State Key Development Program for Basic Research of China (Grant No. 2017YFC1103302), the State Key Laboratory of Trauma, Burns and Combined Injury Research Foundation (Grant No. SKLYQ201802), and the National Nature Science Foundation of China (Grant No. 81473222).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2019.00368/full#supplementary-material
Footnotes
References
1
AkhmanovaA.SteinmetzM. O. (2015). Control of microtubule organization and dynamics: two ends in the limelight.Nat. Rev. Mol. Cell Biol.16711–726. 10.1038/nrm4084
2
BanyardD. A.AdnaniB. O.MelkumyanS.AraniegoC. A.WidgerowA. D. (2016). Endothelial progenitor cells and burn injury - exploring the relationship.Burns Trauma4:4. 10.1186/s41038-016-0028-x
3
CassimerisL. (2002). The oncoprotein 18/stathmin family of microtubule destabilizers.Curr. Opin. Cell Biol.1418–24. 10.1016/S0955-0674(01)00289-7
4
ChangW.GruberD.ChariS.KitazawaH.HamazumiY.HisanagaS.et al (2001). Phosphorylation of MAP4 affects microtubule properties and cell cycle progression.J. Cell Sci.1142879–2887.
5
ChenX.ZhangS.WangZ.WangF.CaoX.WuQ.et al (2018). Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.J. Exp. Clin. Cancer Res.37:128. 10.1186/s13046-018-0787-2
6
DiPietroL. A. (2013). Angiogenesis and scar formation in healing wounds.Curr. Opin. Rheumatol.2587–91. 10.1097/BOR.0b013e32835b13b6
7
FalangaV. (1988). Occlusive wound dressings. Why, when, which?.Arch. Dermatol.124872–877. 10.1001/archderm.1988.01670060018009
8
GiampietroC.LuzzatiF.GambarottaG.GiacobiniP.BodaE.FasoloA.et al (2005). Stathmin expression modulates migratory properties of GN-11 neurons in vitro.Endocrinology1461825–1834. 10.1210/en.2004-0972
9
HirotaY.YamashitaS.KuriharaY.JinX.AiharaM.SaigusaT.et al (2015). Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways.Autophagy11332–343. 10.1080/15548627.2015.1023047
10
HopfH. W.RollinsM. D. (2007). Wounds: an overview of the role of oxygen.Antioxid. Redox Signal.91183–1192. 10.1089/ars.2007.1641
11
HuJ.ChuZ.HanJ.ZhangQ.ZhangD.DangY.et al (2014). Phosphorylation-dependent mitochondrial translocation of MAP4 is an early step in hypoxia-induced apoptosis in cardiomyocytes.Cell Death Dis.5:e1424. 10.1038/cddis.2014.369
12
HuJ. Y.ChuZ. G.HanJ.DangY. M.YanH.ZhangQ.et al (2010). The p38/MAPK pathway regulates microtubule polymerization through phosphorylation of MAP4 and Op18 in hypoxic cells.Cell. Mol. Life Sci.67321–333. 10.1007/s00018-009-0187-z
13
HuangC.JacobsonK.SchallerM. D. (2004). MAP kinases and cell migration.J. Cell Sci.117(Pt 20), 4619–4628. 10.1242/jcs.01481
14
JiangY. Y.ShangL.ShiZ. Z.ZhangT. T.MaS.LuC. C.et al (2016). Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma.Oncogene354846–4856. 10.1038/onc.2016.17
15
JosephJ. V.ConroyS.PavlovK.SontakkeP.TomarT.Eggens-MeijerE.et al (2015). Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis.Cancer Lett.359107–116. 10.1016/j.canlet.2015.01.010
16
KaverinaI.StraubeA. (2011). Regulation of cell migration by dynamic microtubules.Semin. Cell Dev. Biol.22968–974. 10.1016/j.semcdb.2011.09.017
17
KimE. K.ChoiE. J. (2010). Pathological roles of MAPK signaling pathways in human diseases.Biochim. Biophys. Acta1802396–405. 10.1016/j.bbadis.2009.12.009
18
KitazawaH.IidaJ.UchidaA.Haino-FukushimaK.ItohT. J.HotaniH.et al (2000). Ser787 in the proline-rich region of human MAP4 is a critical phosphorylation site that reduces its activity to promote tubulin polymerization.Cell Struct. Funct.2533–39. 10.1247/csf.25.33
19
KreitzerG.MyatM. M. (2018). Microtubule motors in establishment of epithelial cell polarity.Cold Spring Harb. Perspect. Biol.10:a027896. 10.1101/cshperspect.a027896
20
KremerB. E.HaysteadT.MacaraI. G. (2005). Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4.Mol. Biol. Cell164648–4659. 10.1091/mbc.e05-03-0267
21
LaFlammeS. E.Mathew-SteinerS.SinghN.Colello-BorgesD.NievesB. (2018). Integrin and microtubule crosstalk in the regulation of cellular processes.Cell. Mol. Life Sci.754177–4185. 10.1007/s00018-018-2913-x
22
LamaliceL.Le BoeufF.HuotJ. (2007). Endothelial cell migration during angiogenesis.Circ. Res.100782–794. 10.1161/01.RES.0000259593.07661.1e
23
LiL.HuJ.HeT.ZhangQ.YangX.LanX.et al (2015). P38/MAPK contributes to endothelial barrier dysfunction via MAP4 phosphorylation-dependent microtubule disassembly in inflammation-induced acute lung injury.Sci. Rep.5:8895. 10.1038/srep08895
24
LiL.ZhangQ.ZhangX.ZhangJ.WangX.RenJ.et al (2018). Microtubule associated protein 4 phosphorylation leads to pathological cardiac remodeling in mice.EBioMedicine37221–235. 10.1016/j.ebiom.2018.10.017
25
LiN.JiangP.DuW.WuZ.LiC.QiaoM.et al (2011). Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules.Proc. Natl. Acad. Sci. U.S.A.10812851–12856. 10.1073/pnas.1017372108
26
LiuB. P.Chrzanowska-WodnickaM.BurridgeK. (1998). Microtubule depolymerization induces stress fibers, focal adhesions, and DNA synthesis via the GTP-binding protein Rho.Cell Adhes Commun.5249–255. 10.3109/15419069809040295
27
Munoz-ChapuliR.QuesadaA. R.Angel MedinaM. (2004). Angiogenesis and signal transduction in endothelial cells.Cell. Mol. Life Sci.612224–2243. 10.1007/s00018-004-4070-7
28
NagarajuG. P.BramhachariP. V.RaghuG.El-RayesB. F. (2015). Hypoxia inducible factor-1alpha: its role in colorectal carcinogenesis and metastasis.Cancer Lett.36611–18. 10.1016/j.canlet.2015.06.005
29
OokataK.HisanagaS.BulinskiJ. C.MurofushiH.AizawaH.ItohT. J.et al (1995). Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics.J. Cell Biol.128849–862. 10.1083/jcb.128.5.849
30
O’TooleE. A.MarinkovichM. P.PeaveyC. L.AmievaM. R.FurthmayrH.MustoeT. A.et al (1997). Hypoxia increases human keratinocyte motility on connective tissue.J. Clin. Invest.1002881–2891. 10.1172/JCI119837
31
OuY.ZhengX.GaoY.ShuM.LengT.LiY.et al (2014). Activation of cyclic AMP/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics.Urol. Oncol.32e21–e28. 10.1016/j.urolonc.2013.06.017
32
ParkE. C.RongoC. (2016). The p38 MAP kinase pathway modulates the hypoxia response and glutamate receptor trafficking in aging neurons.eLife5:e12010. 10.7554/eLife.12010
33
ParysekL. M.AsnesC. F.OlmstedJ. B. (1984). MAP 4: occurrence in mouse tissues.J. Cell Biol.99(4 Pt 1), 1309–1315. 10.1083/jcb.99.4.1309
34
PutnamA. J.CunninghamJ. J.DennisR. G.LindermanJ. J.MooneyD. J. (1998). Microtubule assembly is regulated by externally applied strain in cultured smooth muscle cells.J. Cell Sci.111(Pt 22), 3379–3387.
35
RamkumarA.JongB. Y.Ori-McKenneyK. M. (2018). ReMAPping the microtubule landscape: how phosphorylation dictates the activities of microtubule-associated proteins.Dev. Dyn.247138–155. 10.1002/dvdy.24599
36
SalicA.MitchisonT. J. (2008). A chemical method for fast and sensitive detection of DNA synthesis in vivo.Proc. Natl. Acad. Sci. U.S.A.1052415–2420. 10.1073/pnas.0712168105
37
SrsenV.KitazawaH.SugitaM.MurofushiH.BulinskiJ. C.KishimotoT.et al (1999). Serum-dependent phosphorylation of human MAP4 at Ser696 in cultured mammalian cells.Cell Struct. Funct.24321–327. 10.1247/csf.24.321
38
SteinmetzM. O.ProtaA. E. (2018). Microtubule-targeting agents: strategies to hijack the cytoskeleton.Trends Cell Biol.28776–792. 10.1016/j.tcb.2018.05.001
39
StramucciL.PrantedaA.BossiG. (2018). Insights of crosstalk between p53 protein and the MKK3/MKK6/p38 MAPK signaling pathway in cancer.Cancer10:E131. 10.3390/cancers10050131
40
XiaX.HeC.WuA.ZhouJ.WuJ. (2018). Microtubule-associated protein 4 is a prognostic factor and promotes tumor progression in lung adenocarcinoma.Dis. Mark.2018:8956072. 10.1155/2018/8956072
41
XingD.LiuL.MartiG. P.ZhangX.ReinblattM.MilnerS. M.et al (2011). Hypoxia and hypoxia-inducible factor in the burn wound.Wound Repair Regenerat.19205–213. 10.1111/j.1524-475X.2010.00656.x
42
YipW. L. (2015). Influence of oxygen on wound healing.Int. Wound J.12620–624. 10.1111/iwj.12324
43
YouJ.WangZ.XuS.ZhangW.FangQ.LiuH.et al (2016). Advanced glycation end products impair glucose-stimulated insulin secretion of a pancreatic beta-cell line INS-1-3 by disturbance of microtubule cytoskeleton via p38/MAPK activation.J. Diabetes Res.2016:9073037. 10.1155/2016/9073037
44
ZhangJ.ZhangC.JiangX.LiL.ZhangD.TangD.et al (2019). Involvement of autophagy in hypoxia-BNIP3 signaling to promote epidermal keratinocyte migration.Cell Death Dis.10:234. 10.1038/s41419-019-1473-9
45
ZhangJ.ZhangD.YanT.JiangX.ZhangC.ZhaoL.et al (2017). BNIP3 promotes the motility and migration of keratinocyte under hypoxia.Exp. Dermatol.26416–422. 10.1111/exd.13248
Summary
Keywords
microtubule, MAP4, p38/MAPK, cell migration, proliferation
Citation
Zhang J, Li L, Zhang Q, Yang X, Zhang C, Zhang X, Zhang D, Lv Y, Song H, Chen B, Liu Y, Hu J and Huang Y (2019) Phosphorylation of Microtubule- Associated Protein 4 Promotes Hypoxic Endothelial Cell Migration and Proliferation. Front. Pharmacol. 10:368. doi: 10.3389/fphar.2019.00368
Received
30 January 2019
Accepted
25 March 2019
Published
16 April 2019
Volume
10 - 2019
Edited by
Maria Angela Sortino, Università degli Studi di Catania, Italy
Reviewed by
Meilang Xue, The University of Sydney, Australia; Andrea Huwiler, University of Bern, Switzerland
Updates
Copyright
© 2019 Zhang, Li, Zhang, Yang, Zhang, Zhang, Zhang, Lv, Song, Chen, Liu, Hu and Huang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiongyu Hu, jiongyuhu@163.com Yuesheng Huang, yshuang1958@163.com
†These authors have contributed equally to this work
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.